Patients exhibiting high cytoplasmic SIRT1 protein expression profiles showed noticeably reduced rates of disease recurrence and death, suggesting a protective role of cytoplasmic SIRT1 in BC progression. This evidence concerns the gene SIRT1 and breast cancer.